SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000874015-19-000068
Filing Date
2019-05-09
Accepted
2019-05-09 16:37:41
Documents
60
Period of Report
2019-03-31

Document Format Files

Seq Description Document Type Size
1 IONIS PHARMACEUTICALS INC 10-Q 3-31-2019 form10q.htm 10-Q 1492791
2 EXHIBIT 31.1 ex31_1.htm EX-31.1 12803
3 EXHIBIT 31.2 ex31_2.htm EX-31.2 12597
4 EXHIBIT 32.1 ex32_1.htm EX-32.1 6239
  Complete submission text file 0000874015-19-000068.txt   7480793

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT ions-20190331.xml EX-101.INS 1704090
6 XBRL TAXONOMY EXTENSION SCHEMA ions-20190331.xsd EX-101.SCH 49344
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE ions-20190331_cal.xml EX-101.CAL 70529
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE ions-20190331_def.xml EX-101.DEF 312965
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE ions-20190331_lab.xml EX-101.LAB 755555
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ions-20190331_pre.xml EX-101.PRE 421450
Mailing Address 2855 GAZELLE COURT CARLSBAD CA 92010
Business Address 2855 GAZELLE COURT CARLSBAD CA 92010 7609319200
IONIS PHARMACEUTICALS INC (Filer) CIK: 0000874015 (see all company filings)

IRS No.: 330336973 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-19125 | Film No.: 19811196
SIC: 2834 Pharmaceutical Preparations